TestMu AI, formerly LambdaTest Inc., today rebranded itself from a cloud testing platform to become an agentic artificial ...

The annual J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

Pentesting has shifted to continuous delivery, automated validation, and unified workflows to drive real risk reduction in ...

The Copenhagen Test drew in 1.1 billion views upon release, mixing high-concept sci-fi with a twisty spy narrative and an ...

Founded nearly three decades ago, PsychTests.com is the mind behind 200+ scientifically validated psychological assessments used by ...

Discover the leading mobile application testing tools for DevOps teams in 2025, aimed at enhancing performance, stability, and agile release cycles for businesses worldwide.

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

India conducted an unprecedented night test launch of the Agni-Prime medium-range ballistic missile (MRBM) from a rail-based mobile launcher on September 24, according to an Indian Ministry of Defense ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...